Kenvue Inc. KVUE | NYSE
KVUE last paid $0.21 a share on Sep 23, and returned 42.9% over 12 months with dividends counted. · 1-year total return +42.9% · Track KVUE in a free portfolio
Company Overview:
3.5 Year KVUE Performance Metrics:
KVUE Dividend Charts
Build Custom Charts
KVUE Financials: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:
Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:
Ratios, Profit Margins & Return on Capital:
KVUE Dividends Info:
Projected Future Returns & Dividends for KVUE
Based on past 3.5-year performance, here are KVUE growth metrics:
Share price CAGR of -9.04%
Dividend CAGR of +1.62%
Using KVUE CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:
| KVUE (DRIP) | KVUE - No DRIP | |
|---|---|---|
| Current Price | $19.31 | $19.31 |
| Start Shares | 517.87 | 517.87 |
| Start Value | $10,000 | $10,000 |
| After 10 years: | ||
| Final Share Count | 971.34 | 517.87 |
| Dividends Payment | $0.24 | $0.24 |
| Annual Dividends | $943 | $502 |
| Yield on cost | 9.43% | 5.02% |
| Share Price | $8.23 | $8.23 |
| Total Dividends | $5,521 | $4,178 |
| Final Value | $7,997 | $8,442 |
NOTE: Above numbers are our estimate based on KVUE's Dividend and Price CAGR over past 3.5 years.
These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.
We cannot guarantee that your actual returns will meet these estimates.
Company Info
Kenvue Inc. (KVUE) had its IPO on 2023-05-04, and is traded on NYSE stock exchange.
Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
KVUE website: https://www.kenvue.com
DCF Model — KVUE
FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.
EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.
| Year | FCF | Implied price |
|---|
